Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Iris, Breitkreutz"'
Autor:
Kosima Zuern, Thomas Hielscher, Annika Werly, Iris Breitkreutz, Sandra Sauer, Marc S. Raab, Carsten Müller-Tidow, Hartmut Goldschmidt, Elias K. Mai
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Risk of progression of monoclonal gammopathy of undetermined significance (MGUS) into multiple myeloma and related plasma cell disorders can be determined by three major risk stratification models, namely Mayo2005, Sweden2014, and NCI2019. T
Externí odkaz:
https://doaj.org/article/8b59e6031f2a4f8abcea173fdef09306
Autor:
Xiang Zhou, Patrick Costello, Anita Schmitt, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Max Topp, Hartmut Goldschmidt, Hermann Einsele, Nikhil C Munshi, Marc S Raab, Joseph Kauer, Thomas Hielscher, Niels Weinhold, Mirco J Friedrich, Sandra Sauer, Leo Rasche, Thomas Luft, Jan H Frenking, Vivien Wagner, Elias K Mai, Christian S Michel, Marina Hajiyianni, Iris Breitkreutz, Omar Nadeem, Adam S Sperling
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 10 (2024)
Background Chimeric antigen receptor (CAR) T-cell therapy has demonstrated significant benefits in the treatment of relapsed/refractory multiple myeloma (RRMM). However, these outcomes can be compromised by severe complications, including cytokine re
Externí odkaz:
https://doaj.org/article/8940433ced884d68a993840e8bd1f4cb
Autor:
Simone Feurstein, Julian Zoller, Constantin Schwab, Sarah Schreiner, Heiko Mundt, Iris Breitkreutz, Brigitte Schneider, Jörg Beimler, Martin Zeier, Rüdiger Waldherr, Stefan Gröschel, Carsten Müller‐Tidow, Stefan O. Schönland, Ute Hegenbart
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1377-1380 (2022)
Abstract Due to differences in the protein folding mechanisms, it is exceedingly rare for amyloid light chain (AL) amyloidosis and monoclonal gammopathy of renal significance (MGRS) to coexist. We herein report the first case of concurrent AL amyloid
Externí odkaz:
https://doaj.org/article/762da7cf1a1d491ba281f9f797e23edf
Autor:
Alwin Krämer, Mads H. Clausen, Kenneth C. Anderson, Hartmut Goldschmidt, Anthony D. Ho, Uwe Haberkorn, Walter Mier, Felix Nissen, Johannes Fruehauf, Klaus Podar, Patrick J. Hayden, Gleb Konotop, Ludmila Weiz, Thomas O. Larsen, Blanka Leber, Mads H. Rønnest, Simon Anderhub, Iris Breitkreutz, Marc S. Raab
PDF file - 239K, HeLa-PLK4 cells display centrosome amplification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ca51af8cc8384e8f9fa56cd0cbc13ca
https://doi.org/10.1158/0008-5472.22394585
https://doi.org/10.1158/0008-5472.22394585
Autor:
Alwin Krämer, Mads H. Clausen, Kenneth C. Anderson, Hartmut Goldschmidt, Anthony D. Ho, Uwe Haberkorn, Walter Mier, Felix Nissen, Johannes Fruehauf, Klaus Podar, Patrick J. Hayden, Gleb Konotop, Ludmila Weiz, Thomas O. Larsen, Blanka Leber, Mads H. Rønnest, Simon Anderhub, Iris Breitkreutz, Marc S. Raab
PDF file - 50K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67cf696053a57476d78e93663c46f604
https://doi.org/10.1158/0008-5472.22394573.v1
https://doi.org/10.1158/0008-5472.22394573.v1
Autor:
Alwin Krämer, Mads H. Clausen, Kenneth C. Anderson, Hartmut Goldschmidt, Anthony D. Ho, Uwe Haberkorn, Walter Mier, Felix Nissen, Johannes Fruehauf, Klaus Podar, Patrick J. Hayden, Gleb Konotop, Ludmila Weiz, Thomas O. Larsen, Blanka Leber, Mads H. Rønnest, Simon Anderhub, Iris Breitkreutz, Marc S. Raab
PDF file - 81K, HeLa-PLK4 cells treated with GF-15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024c38b996a34b4a8fe3cdc5deebfdd6
https://doi.org/10.1158/0008-5472.22394582
https://doi.org/10.1158/0008-5472.22394582
Autor:
Alwin Krämer, Mads H. Clausen, Kenneth C. Anderson, Hartmut Goldschmidt, Anthony D. Ho, Uwe Haberkorn, Walter Mier, Felix Nissen, Johannes Fruehauf, Klaus Podar, Patrick J. Hayden, Gleb Konotop, Ludmila Weiz, Thomas O. Larsen, Blanka Leber, Mads H. Rønnest, Simon Anderhub, Iris Breitkreutz, Marc S. Raab
PDF file - 51K, GF-15 significantly increases the mitotic index in MM xenograft tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f7a8eb4d7bdb6a2e31068c72fbbec65
https://doi.org/10.1158/0008-5472.22394576.v1
https://doi.org/10.1158/0008-5472.22394576.v1
Autor:
Alwin Krämer, Mads H. Clausen, Kenneth C. Anderson, Hartmut Goldschmidt, Anthony D. Ho, Uwe Haberkorn, Walter Mier, Felix Nissen, Johannes Fruehauf, Klaus Podar, Patrick J. Hayden, Gleb Konotop, Ludmila Weiz, Thomas O. Larsen, Blanka Leber, Mads H. Rønnest, Simon Anderhub, Iris Breitkreutz, Marc S. Raab
PDF file - 69K, GF-15 decreases tumor growth in a HT29 xenograft mouse model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9ce06e6e0d93ae39106f20d437d19db
https://doi.org/10.1158/0008-5472.22394579
https://doi.org/10.1158/0008-5472.22394579
Autor:
Alwin Krämer, Mads H. Clausen, Kenneth C. Anderson, Hartmut Goldschmidt, Anthony D. Ho, Uwe Haberkorn, Walter Mier, Felix Nissen, Johannes Fruehauf, Klaus Podar, Patrick J. Hayden, Gleb Konotop, Ludmila Weiz, Thomas O. Larsen, Blanka Leber, Mads H. Rønnest, Simon Anderhub, Iris Breitkreutz, Marc S. Raab
PDF file - 60K, GF-15 does not induce spindle multipolarity in resistant cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317a616a185e32d4f48c6dde11943300
https://doi.org/10.1158/0008-5472.22394588.v1
https://doi.org/10.1158/0008-5472.22394588.v1
Autor:
Henk M. Lokhorst, Ingo Schmidt-Wolf, Pieter Sonneveld, Bronno van der Holt, Hans Martin, Rene Barge, Uta Bertsch, Jana Schlenzka, Gerard M.J. Bos, Sandra Croockewit, Sonja Zweegman, Iris Breitkreutz, Peter Joosten, Christof Scheid, Marinus van Marwijk-Kooy, Hans-Juergen Salwender, Marinus H.J. van Oers, Ron Schaafsma, Ralph Naumann, Harm Sinnige, Igor Blau, Michel Delforge, Okke de Weerdt, Pierre Wijermans, Shulamiet Wittebol, Ulrich Duersen, Edo Vellenga, Hartmut Goldschmidt
Publikováno v:
Haematologica, Vol 93, Iss 1 (2008)
In the prospective phase 3 HOVON-50/GMMG-HD3 trial, patients randomized to TAD (thalidomide, doxorubicin, dexamethasone) had a significantly higher response rate (at least PR) after induction compared with patients randomized to VAD (vincristine, adr
Externí odkaz:
https://doaj.org/article/cde5267fd127455282cfd518e36718c1